All Stories

  1. Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment

    Article • Current Medicinal Chemistry, December 2019, Bentham Science Publishers

    Dr Milica S Pesic

  2. Modulation of Antioxidant Potential with Coenzyme Q10 Suppressed Invasion of Temozolomide-Resistant Rat Glioma In Vitro and In Vivo

    Article • Oxidative Medicine and Cellular Longevity, March 2019, Hindawi Publishing Corporation

    Ignacio Ochoa, Dr Milica S Pesic

  3. Design, synthesis, and biological evaluation of novel derivatives of dithiodiglycolic acid prepared via oxidative coupling of thiols

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2019, Taylor & Francis

    Dr Milica S Pesic

  4. Selective Anti-Cancer Drugs against Multi-drug Resistance

    Article • December 2018, Bentham Science Publishers

    Dr Milica S Pesic

  5. Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma

    Article • Cellular Oncology, November 2016, Springer Science + Business Media

    Dr Milica S Pesic

  6. Applied mathematics and nonlinear sciences in the war on cancer

    Article • Applied Mathematics and Nonlinear Sciences, October 2016, UP4 Institute of Sciences, S.L.

    Dr Milica S Pesic

  7. Simple avarone mimetics as selective agents against multidrug resistant cancer cells

    Article • European Journal of Medicinal Chemistry, August 2016, Elsevier

    Dr Milica S Pesic

  8. Resistance to DNA Damaging Agents Produced Invasive Phenotype of Rat Glioma Cells—Characterization of a New in Vivo Model

    Article • Molecules, June 2016, MDPI AG

    Dr Milica S Pesic

  9. Transfer of Drug Resistance Characteristics Between Cancer Cell Subpopulations: A Study Using Simple Mathematical Models

    Article • The Bulletin of Mathematical Biophysics, June 2016, Springer Science + Business Media

    Dr Milica S Pesic

  10. Structural differences in diarylheptanoids analogues from Alnus viridis and Alnus glutinosa influence their activity and selectivity towards cancer cells

    Article • Chemico-Biological Interactions, April 2016, Elsevier

    Dr Milica S Pesic

  11. Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models

    Article • Current Cancer Drug Targets, February 2016, Bentham Science Publishers

    Dr Milica S Pesic

  12. Secondary Metabolite Profile of Transgenic Centaury (Centaurium erythraea Rafn.) Plants, Potential Producers of Anticancer Compounds

    Article • January 2016, Springer Science + Business Media

    Dr Milica S Pesic

  13. Mutual regulation and targeting of multidrug resistance and cancer stem phenotype

    Article • MedChemComm, January 2016, Royal Society of Chemistry

    Dr Milica S Pesic

  14. Secondary Metabolite Profile of Transgenic Centaury (Centaurium erythraea Rafn.) Plants, Potential Producers of Anticancer Compounds

    Article • January 2016, Springer Science + Business Media

    Dr Milica S Pesic

  15. New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer

    Article • Current Pharmaceutical Design, November 2015, Bentham Science Publishers

    Dr Milica S Pesic

  16. Chemo-protective and regenerative effects of diarylheptanoids from the bark of black alder (Alnus glutinosa) in human normal keratinocytes

    Article • Fitoterapia, September 2015, Elsevier

    Dr Milica S Pesic

  17. Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives

    Article • Cancer Chemotherapy and Pharmacology, July 2015, Springer Science + Business Media

    Dr Milica S Pesic

  18. Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin

    Article • Experimental Cell Research, July 2015, Elsevier

    Dr Milica S Pesic

  19. Association of CCND1 overexpression with KRAS and PTEN alterations in specific subtypes of non-small cell lung carcinoma and its influence on patients’ outcome

    Article • Tumor Biology, June 2015, Springer Science + Business Media

    Dr Milica S Pesic

  20. Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity

    Article • Chemico-Biological Interactions, May 2015, Elsevier

    Dr Milica S Pesic

  21. Purine nucleoside analogs in the therapy of cancer and neuroinflammation

    Article • Molecular inhibitors in targeted therapy, January 2015, De Gruyter

    Dr Milica S Pesic

  22. Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma

    Article • Translational Research, November 2014, Elsevier

    Dr Milica S Pesic

  23. Antioxidative Activity of Diarylheptanoids from the Bark of Black Alder (Alnus glutinosa) and Their Interaction with Anticancer Drugs

    Article • Planta Medica, August 2014, Thieme Publishing Group

    Dr Milica S Pesic

  24. Targeted Anti-Cancer Therapy, Acquiring and Overcoming Multi-Drug Resistance

    Article • May 2014, Bentham Science Publishers

    Dr Milica S Pesic, Nikola Tanic

  25. Elucidation and in planta reconstitution of the parthenolide biosynthetic pathway

    Article • Metabolic Engineering, May 2014, Elsevier

    Dr Milica S Pesic

  26. Discovery of 14-3-3 Protein-Protein Interaction Inhibitors that Sensitize Multidrug-Resistant Cancer Cells to Doxorubicin and the Akt Inhibitor GSK690693

    Article • ChemMedChem, April 2014, Wiley

    Dr Milica S Pesic

  27. Two structurally distinct chalcone dimers from Helichrysum zivojinii and their activities in cancer cell lines

    Article • Phytochemistry, February 2014, Elsevier

    Dr Milica S Pesic

  28. Diarylheptanoids from the bark of black alder inhibit the growth of sensitive and multi-drug resistant non-small cell lung carcinoma cells

    Article • Phytochemistry, January 2014, Elsevier

    Dr Milica S Pesic

  29. No-Modified Saquinavir is Equally Efficient Against Doxorubicin Sensitive and Resistant Non-Small Cell Lung Carcinoma Cells / MODIFIKOVANA KOVANA FORMA SAKVINAVIRA EFIKASNO SU PRIMI RA RAST ĆELIJA NESITNOĆELIJSKOG KARCINOMA PLUĆA RAZLIČITE OSETUIVOSTI ...

    Article • Journal of Medical Biochemistry, October 2013, Centre for Evaluation in Education and Science (CEON/CEES)

    Professor Djordje Miljkovic, Dr Milica S Pesic

  30. Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing

    Article • Cancer Chemotherapy and Pharmacology, August 2013, Springer Science + Business Media

    Dr Milica S Pesic

  31. Cytotoxic activity of sesquiterpene lactones from Inula britannica on human cancer cell lines

    Article • Phytochemistry Letters, May 2013, Elsevier

    Dr Milica S Pesic

  32. Synthesis, characterization and cytotoxicity of a new palladium(II) complex with a coumarin-derived ligand. Crystal structure of 4-hydroxy-3-(1-(p-tolylimino)ethyl)-2H-chromen-2-one-palladium(II) complex

    Article • Journal of Molecular Structure, May 2013, Elsevier

    Dr Milica S Pesic

  33. The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: The unique way of multi-drug resistance modulation

    Article • Experimental Cell Research, April 2013, Elsevier

    Professor Djordje Miljkovic, Dr Milica S Pesic

  34. Jatrophane diterpenoids from the latex of Euphorbia dendroides and their anti-P-glycoprotein activity in human multi-drug resistant cancer cell lines

    Article • Phytochemistry, February 2013, Elsevier

    Dr Vele Tešević, Dr Milica S Pesic

  35. Purine Nucleoside Analog - Sulfinosine Modulates Diverse Mechanisms of Cancer Progression in Multi-Drug Resistant Cancer Cell Lines

    Article • PLoS ONE, January 2013, PLOS

    Dr Milica S Pesic

  36. Genomic instability and p53 alterations in patients with malignant glioma

    Article • Experimental and Molecular Pathology, October 2012, Elsevier

    Dr Milica S Pesic

  37. New anti-cancer characteristics of jatrophane diterpenes from Euphorbia dendroides

    Article • Food and Chemical Toxicology, December 2011, Elsevier

    Dr Vele Tešević, Dr Milica S Pesic

  38. The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines

    Article • Biomedicine & Pharmacotherapy, August 2011, Elsevier

    Dr Milica S Pesic

  39. Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamil

    Article • Investigational New Drugs, June 2009, Springer Science + Business Media

    Dr Milica S Pesic

  40. Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line (NCI-H460/R)

    Article • Cancer Biology & Therapy, July 2008, Taylor & Francis

    Dr Milica S Pesic

  41. Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R)

    Article • Investigational New Drugs, May 2008, Springer Science + Business Media

    Dr Milica S Pesic

  42. The combination of sulfinosine and 8-Cl-cAMP induces synergistic cell growth inhibition of the human neuroblastoma cell line in vitro

    Article • Investigational New Drugs, January 2006, Springer Science + Business Media

    Dr Milica S Pesic

  43. Comparative analysis of expression of angiogenic factors and CD44 gene in human glioma and neuroblastoma cell lines in vitro

    Article • Jugoslovenska medicinska biohemija, January 2004, National Library of Serbia

    Dr Milica S Pesic

  44. 8-Cl-cAMP and tiazofurin affect vascular endothelial growth factor production and glial fibrillary acidic protein expression in human glioblastoma cells

    Article • Anti-Cancer Drugs, October 2000, Wolters Kluwer Health

    Dr Milica S Pesic